Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amoebiasis.

Samuel L Stanley1

  • 1Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO, St Louis, MO 63110, USA. sstanley@im.wustl.edu

Lancet (London, England)
|March 28, 2003
PubMed
Summary
This summary is machine-generated.

Amoebiasis, a deadly parasitic disease, is caused by Entamoeba histolytica. Genetic evidence reveals Entamoeba dispar as a distinct commensal species, changing our understanding of amoebiasis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of acetylsalicylic acid on thrombin generation in healthy volunteers.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same author

Anesthesia Type during Cancer Surgery: Results of the GA-CARES Randomized, Multicenter Trial.

Anesthesiology·2025
Same author

The impact of interval cholecystectomy timing after percutaneous transhepatic cholecystostomy on post-operative adverse outcomes.

Surgical endoscopy·2023
Same author

Differences in the transcriptome signatures of two genetically related Entamoeba histolytica cell lines derived from the same isolate with different pathogenic properties.

BMC genomics·2010
Same author

Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin.

Nature immunology·2009
Same author

Proteomic comparison of Entamoeba histolytica and Entamoeba dispar and the role of E. histolytica alcohol dehydrogenase 3 in virulence.

PLoS neglected tropical diseases·2009
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Parasitology
  • Molecular Biology

Background:

  • Amoebiasis is a significant global parasitic disease, with Entamoeba histolytica identified as the primary pathogen.
  • E. histolytica causes amoebic colitis by invading the intestinal mucosa and can lead to amoebic liver abscesses.
  • Historically, amoebiasis was considered a single-species disease, but recent evidence distinguishes between the pathogenic E. histolytica and the commensal E. dispar.

Purpose of the Study:

  • To elucidate the pathogenic mechanisms of Entamoeba histolytica in amoebic colitis and liver abscess.
  • To differentiate between Entamoeba histolytica and Entamoeba dispar based on genetic evidence.
  • To update the understanding of amoebiasis epidemiology and diagnosis.

Main Methods:

Related Experiment Videos

  • Morphological and genetic analysis to distinguish Entamoeba species.
  • Investigation of E. histolytica's secretion of proteinases and interaction with host cells.
  • Inclusion of new disease models linking E. histolytica to inflammation and cell death.

    • Main Results:

    • Identification of two distinct species: Entamoeba histolytica (pathogen) and Entamoeba dispar (commensal).
    • E. histolytica secretes proteinases, destroys host tissues, and causes red blood cell engulfment.
    • New models implicate E. histolytica in intestinal inflammation and hepatocyte apoptosis.

    Conclusions:

    • The distinction between E. histolytica and E. dispar necessitates revised approaches to amoebiasis diagnosis and epidemiology.
    • Understanding the molecular mechanisms of E. histolytica pathogenicity is crucial for disease control.
    • Amoebic liver abscesses, though severe, are now treatable with antibiotics.